表紙
市場調查報告書
商品編碼
975685

生物銀行的全球市場:標本的各類型,生物銀行的各類型,各所有權,各應用領域,各地區的市場規模調查與展望(2020年∼2027年)

Global Biobanking Market Size study, By Specimen Type, Type of Biobank, Ownership, and Application, and Regional Forecasts 2020-2027

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

生物銀行的市場規模2019年約20億8,000萬美金,在2020年∼2027年的預測期間內預計以超過23.7%的健全的成長率成長。全球生物銀行產業的促進成長的重要要素中,包含來自民間及政府機關的財政支援的擴大。再加上慢性疾病的盛行率改善促進需求的成長。可是,生物銀行相關的倫理性及法規上的疑慮限制事業擴大。

本報告提供生物銀行的世界市場調查,市場概要,市場成長要素及阻礙因素分析,市場機會,各標本的種類、生物銀行的種類、所有權、應用、地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 摘要整理

第2章 市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查範圍
    • 產業的演進
  • 調查對象年度
  • 匯率

第3章 市場動態

  • 市場影響分析(2018年∼2027年)

第4章 產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論

第5章 各標本類型

  • 市場概述
  • 效能:各潛力分析
  • 估計與預測:2017年∼2027年(10億美元單位)
  • 子區隔分析
    • 血液製劑
    • 固態組織
    • 細胞株
    • 核酸
    • 其他

第6章 生物銀行的各類型

  • 市場概述
  • 效能:各潛力分析
  • 估計與預測:2017年∼2027年(10億美元單位)
    • 人口為基礎的
    • 病為基礎的

第7章 各應用領域

  • 市場概述
  • 效能:各潛力分析
  • 估計與預測:2017年∼2027年(10億美元單位)
    • 治療
    • 調查

第8章 各所有權

  • 市場概述
  • 效能:各潛力分析
  • 估計與預測:2017年∼2027年(10億美元單位)
    • 國家、地區的機關
    • 非營利團體
    • 大學
    • 民間組織

第9章 各地區

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲的概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 亞太地區的概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美的概述
    • 巴西
    • 墨西哥
  • 其他地區

第10章 競爭情形

  • 最高市場策略
  • 企業簡介
    • Thermo Fisher Scientific Inc.
    • Panasonic Healthcare Holdings Co., Ltd.
    • Becton, Dickinson and Company
    • Qiagen N.V.
    • Merck KGaA
    • VWR Corporation
    • Tecan Trading AG
    • Brooks Automation, Inc.
    • Chart Industries, Inc.
    • Hamilton Company
    • Greiner Holding AG
    • Promega Corporation

第11章 調查流程

目錄

Title:
Global Biobanking Market Size study, By Specimen Type (Blood Products, Solid Tissue, Nucleic Acid, and Cell Lines, Others), Type of Biobank (Population-based Biobanks and Disease-oriented Biobanks), Ownership (National/Regional Agencies, Nonprofit Organization, University, and Private Organization), and Application (Therapeutic and Research), and Regional Forecasts 2020-2027.

Global Biobanking Market is valued approximately at USD 2.08 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 23.7% over the forecast period 2020-2027. Biobanking is a method for gathering and storing biological resources that can be further used for diagnostics, ecosystem studies and analysis. Significant factors driving the growth of the global biobanking industry include expanded financial support from private and government organizations. In addition, an improvement in the prevalence of chronic diseases is driving demand growth. However, ethical and regulatory concerns related to biobanking are restricting business expansion. The emergence of the COVID-19 pandemic has taken the relevance of biobanks across the globe to the forefront. As a result, the rapid establishment of the COVID-19 biobank worldwide has witnessed the prospective selection of research biospecimens and the related clinical and patient data generated by COVID-19 patients with reported infection with the novel SARS-CoV-2 virus to allow high-quality research. For example, NHRI Biobank, Minister of Health and Welfare, was assigned to create a COVID-19 biobank at the beginning of February 2020 to collect blood samples of COVID-19 patients in an evolving way for Taiwanese researchers and industry. Both aspects are projected to have an impact on the biobanking industry in the future. The outbreak of the pandemic has also had a positive impact on the expansion of the biobanking market. Several chronic illnesses, such as cancer, cardiovascular disease, neurological disorders and immunological disorders, cannot be treated with traditional treatment due to adverse side effects. The risk of these side effects may be minimized by incorporating it into stem cell therapy, which serves as a curing agent to mitigate the harm caused by treatment doses. According to figures from the National Cancer Center, about 9.5 million people were confirmed to have cancer in the U.S. in 2019, and this figure is projected to rise to 19 million in 2024. Hence, the demand for cord blood for medicinal purposes, stimulating the development of the biobanking market.

The regional analysis of global Biobanking Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia-Pacific offers attractive prospects for major players operating in the biobanking industry due to a growth in population and the presence of a large geriatric population base. In addition, the increase in health spending and the developing guidlines are expected to fuel demand growth in the country.

Major market player included in this report are:

  • Thermo Fisher Scientific Inc.
  • Panasonic Healthcare Holdings Co., Ltd.
  • Becton, Dickinson and Company
  • Qiagen N.V.
  • Merck KGaA
  • VWR Corporation
  • Tecan Trading AG
  • Brooks Automation, Inc.
  • Chart Industries, Inc.
  • Hamilton Company
  • Greiner Holding AG
  • Promega Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Specimen Type:

  • Blood Products
  • Solid Tissue
  • Cell Lines
  • Nucleic Acid
  • Others

By Type of Biobank:

  • Population-based Biobanks
  • Disease-oriented Biobanks

By Application:

  • Therapeutic
  • Research

By Ownership:

  • National/Regional Agencies
  • Non-profit Organization
  • University
  • Private Organization

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2017, 2018
  • Base year - 2019
  • Forecast period - 2020 to 2027

Target Audience of the Global Biobanking Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Biobanking Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Biobanking Market, by Specimen Type, 2018-2027 (USD Billion)
    • 1.2.3. Biobanking Market, by Type of Biobank, 2018-2027 (USD Billion)
    • 1.2.4. Biobanking Market, by Application, 2018-2027 (USD Billion)
    • 1.2.5. Biobanking Market, by Ownership, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Biobanking Market Definition & Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Biobanking Market Dynamics

  • 3.1. Biobanking Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Biobanking Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Biobanking Market, by Specimen Type

  • 5.1. Market Snapshot
  • 5.2. Global Biobanking Market by Specimen Type, Performance - Potential Analysis
  • 5.3. Global Biobanking Market Estimates & Forecasts by Specimen Type, 2017-2027 (USD Billion)
  • 5.4. Biobanking Market, Sub Segment Analysis
    • 5.4.1. Blood Products
    • 5.4.2. Solid Tissue
    • 5.4.3. Cell Lines
    • 5.4.4. Nucleic Acid
    • 5.4.5. Others

Chapter 6. Global Biobanking Market, by Type of Biobank

  • 6.1. Market Snapshot
  • 6.2. Global Biobanking Market by Type of Biobank, Performance - Potential Analysis
  • 6.3. Global Biobanking Market Estimates & Forecasts by Type of Biobank, 2017-2027 (USD Billion)
    • 6.3.1. Population-based Biobanks
    • 6.3.2. Disease-oriented Biobanks

Chapter 7. Global Biobanking Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Biobanking Market by Application, Performance - Potential Analysis
  • 7.3. Global Biobanking Market Estimates & Forecasts by Application, 2017-2027 (USD Billion)
    • 7.3.1. Therapeutic
    • 7.3.2. Research

Chapter 8. Global Biobanking Market, by Ownership

  • 8.1. Market Snapshot
  • 8.2. Global Biobanking Market by Ownership, Performance - Potential Analysis
  • 8.3. Global Biobanking Market Estimates & Forecasts by Ownership, 2017-2027 (USD Billion)
    • 8.3.1. National/Regional Agencies
    • 8.3.2. Non-profit Organization
    • 8.3.3. University
    • 8.3.4. Private Organization

Chapter 9. Global Biobanking Market, Regional Analysis

  • 9.1. Biobanking Market, Regional Market Snapshot
  • 9.2. North America Biobanking Market
    • 9.2.1. U.S. Biobanking Market
      • 9.2.1.1. Specimen Type breakdown estimates & forecasts, 2017-2027
      • 9.2.1.2. Type of Biobank breakdown estimates & forecasts, 2017-2027
      • 9.2.1.3. Application breakdown estimates & forecasts, 2017-2027
      • 9.2.1.4. Ownership breakdown estimates & forecasts, 2017-2027
    • 9.2.2. Canada Biobanking Market
  • 9.3. Europe Biobanking Market Snapshot
    • 9.3.1. U.K. Biobanking Market
    • 9.3.2. Germany Biobanking Market
    • 9.3.3. France Biobanking Market
    • 9.3.4. Spain Biobanking Market
    • 9.3.5. Italy Biobanking Market
    • 9.3.6. Rest of Europe Biobanking Market
  • 9.4. Asia-Pacific Biobanking Market Snapshot
    • 9.4.1. China Biobanking Market
    • 9.4.2. India Biobanking Market
    • 9.4.3. Japan Biobanking Market
    • 9.4.4. Australia Biobanking Market
    • 9.4.5. South Korea Biobanking Market
    • 9.4.6. Rest of Asia Pacific Biobanking Market
  • 9.5. Latin America Biobanking Market Snapshot
    • 9.5.1. Brazil Biobanking Market
    • 9.5.2. Mexico Biobanking Market
  • 9.6. Rest of The World Biobanking Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Thermo Fisher Scientific Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Industry Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Panasonic Healthcare Holdings Co., Ltd.
    • 10.2.3. Becton, Dickinson and Company
    • 10.2.4. Qiagen N.V.
    • 10.2.5. Merck KGaA
    • 10.2.6. VWR Corporation
    • 10.2.7. Tecan Trading AG
    • 10.2.8. Brooks Automation, Inc.
    • 10.2.9. Chart Industries, Inc.
    • 10.2.10. Hamilton Company
    • 10.2.11. Greiner Holding AG
    • 10.2.12. Promega Corporation

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. GLOBAL BIOBANKING MARKET, REPORT SCOPE
  • TABLE 2. GLOBAL BIOBANKING MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
  • TABLE 3. GLOBAL BIOBANKING MARKET ESTIMATES & FORECASTS BY SPECIMEN TYPE 2017-2027 (USD BILLION)
  • TABLE 4. GLOBAL BIOBANKING MARKET ESTIMATES & FORECASTS BY TYPE OF BIOBANK 2017-2027 (USD BILLION)
  • TABLE 5. GLOBAL BIOBANKING MARKET ESTIMATES & FORECASTS BY APPLICATION 2017-2027 (USD BILLION)
  • TABLE 6. GLOBAL BIOBANKING MARKET ESTIMATES & FORECASTS BY OWNERSHIP 2017-2027 (USD BILLION)
  • TABLE 7. GLOBAL BIOBANKING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 8. GLOBAL BIOBANKING MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 9. GLOBAL BIOBANKING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 10. GLOBAL BIOBANKING MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 11. GLOBAL BIOBANKING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 12. GLOBAL BIOBANKING MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 13. GLOBAL BIOBANKING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 14. GLOBAL BIOBANKING MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 15. GLOBAL BIOBANKING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 16. GLOBAL BIOBANKING MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 17. U.S. BIOBANKING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 18. U.S. BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 19. U.S. BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 20. CANADA BIOBANKING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 21. CANADA BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 22. CANADA BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 23. UK BIOBANKING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 24. UK BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 25. UK BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 26. GERMANY BIOBANKING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 27. GERMANY BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 28. GERMANY BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 29. ROE BIOBANKING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 30. ROE BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 31. ROE BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 32. CHINA BIOBANKING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 33. CHINA BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 34. CHINA BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 35. INDIA BIOBANKING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 36. INDIA BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 37. INDIA BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 38. JAPAN BIOBANKING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 39. JAPAN BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 40. JAPAN BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 41. ROAPAC BIOBANKING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 42. ROAPAC BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 43. ROAPAC BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 44. BRAZIL BIOBANKING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 45. BRAZIL BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 46. BRAZIL BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 47. MEXICO BIOBANKING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 48. MEXICO BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 49. MEXICO BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 50. ROLA BIOBANKING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 51. ROLA BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 52. ROLA BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 53. ROW BIOBANKING MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 54. ROW BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 55. ROW BIOBANKING MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 56. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BIOBANKING MARKET
  • TABLE 57. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BIOBANKING MARKET
  • TABLE 58. YEARS CONSIDERED FOR THE STUDY
  • TABLE 59. EXCHANGE RATES CONSIDERED

LIST OF FIGURES

  • FIG 1. GLOBAL BIOBANKING MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL BIOBANKING MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL BIOBANKING MARKET, KEY TRENDS 2019
  • FIG 5. GLOBAL BIOBANKING MARKET, GROWTH PROSPECTS 2020-2027
  • FIG 6. GLOBAL BIOBANKING MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL BIOBANKING MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL BIOBANKING MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL BIOBANKING MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 10. GLOBAL BIOBANKING MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 11. GLOBAL BIOBANKING MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 12. GLOBAL BIOBANKING MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 13. GLOBAL BIOBANKING MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 14. GLOBAL BIOBANKING MARKET, REGIONAL SNAPSHOT 2017 & 2027
  • FIG 15. NORTH AMERICA BIOBANKING MARKET 2017 & 2027 (USD BILLION)
  • FIG 16. EUROPE BIOBANKING MARKET 2017 & 2027 (USD BILLION)
  • FIG 17. ASIA PACIFIC BIOBANKING MARKET 2017 & 2027 (USD BILLION)
  • FIG 18. LATIN AMERICA BIOBANKING MARKET 2017 & 2027 (USD BILLION)
  • FIG 19. GLOBAL BIOBANKING MARKET, COMPANY MARKET SHARE ANALYSIS (2019)